SCHH vs XBI
Schwab US REIT ETF vs SPDR S&P Biotech ETF
SCHH$23.75
Schwab US REIT ETF
US REITs at very low cost.
Expense: 0.07%Yield: 2.94%
XBI$156.41
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: 0.35%Yield: 0.35%
Quick take
- • SCHH has the lower expense ratio at 0.07% vs 0.35% for XBI.
- • SCHH pays a higher dividend yield (2.94%).
Side-by-side metrics
| Metric | SCHH | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.07% | 0.35% |
Dividend yield Trailing 12-month yield. | 2.94% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $11.04B | $10.92B |
YTD return | 16.54% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.91 | 1.01 |
P/E ratio | 29.99 | — |
Last price | $23.75 | $156.41 |
Inception | — | — |
Issuer | Schwab | State Street |
SCHH top holdings
Top holdings · SCHH
| WELL | Welltower Inc | 9.99% |
| PLD | Prologis Inc | 8.30% |
| AMT | American Tower Corp | 4.97% |
| SPG | Simon Property Group Inc | 4.74% |
| EQIX | Equinix Inc | 4.55% |
| DLR | Digital Realty Trust Inc | 4.50% |
| PSA | Public Storage | 3.92% |
| O | Realty Income Corp | 3.86% |
| VMRK | Vivmark Residential | 3.20% |
| VTR | Ventas Inc | 3.12% |
Sector breakdown · SCHH
Real Estate100.0%
XBI top holdings
Top holdings · XBI
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
Sector breakdown · XBI
Financial Services0.6%
Healthcare99.3%
About SCHH
SCHH (Schwab US REIT ETF) is US REITs at very low cost. Managed by Schwab, the fund carries $11.0B in assets under management, an expense ratio of 0.07%, a dividend yield of 2.94%. Its largest holding is Welltower Inc (WELL), which represents 10.0% of the portfolio. Real Estate is the fund's largest sector exposure at 100.0%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.